Senate Democrats today staged an en masse boycott of a committee hearing on the Trump administration’s nominees to lead the U.S. Health & Human Services and Treasury Depts., forcing Republicans to delay the votes on Rep. Tom Price (R-Ga.) and Steve Mnuchin. At least 1 Democrat must be present for the Senate Finance committee votes to take […]
U.S. Treasury Dept.
Medtronic still unfazed by new inversion rules
Medtronic (NYSE:MDT) remains unfazed by the U.S. Treasury Dept.’s push to rein in so-called “inversion” mergers, which allow American companies to re-organized under foreign jurisdictions, after the agency issued new rules on the deals this week. The U.S. government has grappled with a wave of inversions in recent years, including last year’s $50 billion union of Medtronic and Covidien, […]
New inversion rules are unlikely to scuttle Medtronic’s pending $43B merger with Covidien | The week in medtech M&A
New inversion rules unlikely to scuttle Medtronic's $43B Covidien buy
September 24, 2014 by Brad Perriello
TriVascular Tech recall of stent grafts may drag down full-year revenues | Medtech Wall Street news for the week of September 22, 2014
TriVascular Tech's stent graft recall could hurt the bottom line
September 19, 2014 by Arezu Sarvestani
New inversion rules unlikely to scuttle Medtronic’s $43B Covidien buy
Exec at MDT explains how COV gained $43B payout | The week in medtech M&A
Medtronic, Covidien slide on new U.S. inversion rules
